Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 29 (6) , 1107-1119
Abstract
Background: Evidence suggest that diabetes and glycated hemoglobin (HbA1c) levels are associated with cancer risk. However, previous studies have been limited variably by failure to adjust for cancer-specific risk factors (e.g., body mass index), inattention to diabetes duration and use of antidiabetic medications, and failure to stratify by obesity. Methods: We examined the association between diabetes, HbA1c, and cancer risk in the UK Biobank, using data from 476,517 participants (54% women), followed for an average period of 7.1 years. Diabetes was defined on the basis of baseline self-reported diagnosis of diabetes and/or use of diabetes medication, while HbA1c measured at baseline was categorized as low (<31 mmol/mol), normal (31–<39 mmol/mol), increased risk (39–<48 mmol/mol), and high risk for diabetes (≥48 mmol/mol). Multivariable Cox proportional hazards models were used to estimate the association of diabetes and cancer at different anatomical sites, with adjustment for cancer-specific risk factors. Results: Diabetes was associated with increased risk of cancers of the stomach, liver, bladder, endometrium, and lung among smokers, and with decreased risk of prostate cancer. Compared with the normal HbA1c category, the increased risk category was positively associated with risk of cancers of the colon, liver, bladder, and lung among smokers, and the high-risk category was associated with increased risk of cancers of the esophagus, liver, pancreas, and bladder, and with decreased risk of prostate cancer. Conclusions: These results suggest that both diabetes and/or elevated HbA1c are associated with risk of cancer at several anatomic sites. Impact: The associations of diabetes and HbA1c levels with cancer suggest their importance in cancer prevention.Keywords
Funding Information
- Breast Cancer Research Foundation (BCRF-16-137,)
This publication has 42 references indexed in Scilit:
- Diabetes Mellitus and Ovarian Cancer RiskInternational Journal of Gynecological Cancer, 2013
- HbA1C and Cancer Risk in Patients with Type 2 Diabetes – A Nationwide Population-Based Prospective Cohort Study in SwedenPLOS ONE, 2012
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysisPLOS ONE, 2012
- Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studiesCancer Causes & Control, 2011
- Diabetes and CancerDiabetes Care, 2010
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsNew England Journal of Medicine, 2010
- Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinomaWorld Journal of Gastroenterology, 2010
- Cellular and molecular pathways linking inflammation and cancerImmunobiology, 2009
- Glycosylated Hemoglobin and Risk of Colorectal Cancer in Men and Women, the European Prospective Investigation into Cancer and NutritionCancer Epidemiology, Biomarkers & Prevention, 2008
- A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in WomenCancer Research, 2006